Scheme of Amalgamation
13-12-2018: The Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK CH), and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of Companies Act, 2013, approved by the Board of Directors in their meeting held on 3rd December, 2018 has been submitted with National Stock Exchange of India Limited and BSE Limited.
Related Links
- Update on Scheme of Amalgamation - BSEPDF | 164KB (PDF 163.23 KB)
- Update on Scheme of Amalgamation - NSEPDF | 163KB (PDF 162.04 KB)
- NSE Approval of Scheme of ArrangementPDF | 2MB (PDF 1.18 MB)
- BSE Approval of Scheme of ArrangementPDF | 2MB (PDF 1.23 MB)
- Minutes of the Equity Shareholders MeetingPDF | 557KB (PDF 556.96 KB)
- Minutes of Unsecured Creditors MeetingPDF | 521KB (PDF 520.77 KB)
- Attendance Slip - Unsecured Creditors MeetingPDF | 2MB (PDF 1.82 MB)
- Attendance Slip - Equity Shareholders MeetingPDF | 3MB (PDF 2.55 MB)
- Notice for Unsecured Creditors MeetingPDF | 5MB (PDF 4.37 MB)
- Notice for Equity Shareholders MeetingPDF | 16MB (PDF 15.38 MB)
- NCLT Order for conducting MeetingsPDF | 426KB (PDF 425.75 KB)
- Observation Letter - BSEPDF | 166KB (PDF 165.68 KB)
- Observation Letter - NSEPDF | 295KB (PDF 294.93 KB)
- Compliance ReportPDF | 493KB (PDF 492.08 KB)
- Underaking Para 9(a) & (b) of SEBI Circular on Scheme of ArrangementPDF | 749KB (PDF 748.13 KB)
- Auditor CertificatePDF | 1011KB (PDF 1010.79 KB)
- Financial details of last three years of Transferee Company and Transferor CompanyPDF | 478KB (PDF 477.25 KB)
- Fairness OpinionPDF | 2MB (PDF 1.32 MB)
- Audit Committee ReportPDF | 850KB (PDF 849.95 KB)
- Valuation ReportPDF | 371KB (PDF 370.26 KB)
- Draft Scheme of AmalgamationPDF | 731KB (PDF 730.36 KB)
- Pre and Post Shareholding Pattern of the Transferee and Transferor CompanyPDF | 5MB (PDF 4.72 MB)